Online Program Home
My Program

Abstract Details

Activity Number: 144
Type: Invited
Date/Time: Monday, August 1, 2016 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract #318292
Title: Estimands: Are We Estimating What We Intend to Estimate?
Author(s): Mouna Akacha *
Companies: Novartis Pharma AG
Keywords: Adherence ; Causal Inference ; Effectiveness ; Efficacy ; Estimand ; Intention-to-treat
Abstract:

Defining the scientific questions in a clinical trial is crucial to align its planning, design, conduct, analysis and interpretation. However, practical experience shows that oftentimes specific choices in the statistical analysis blur the scientific question either in part or even completely. The need for more clarity was highlighted by the ICH Steering Committee in 2014, which endorsed a Concept Paper suggested to lead to an addendum to ICH E9. In this talk, we will discuss the need for the estimand framework and share recent experiences highlighting characteristics of estimands that may be of regulatory interest.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2016 program

 
 
Copyright © American Statistical Association